Inuling (Bei Jing) Science and Technology Co. Ltd Report issue

Government

Organization Overview

First Clinical Trial
2016
NCT03794232
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Inuling (Bei Jing) Science and Technology Co. Ltd

Active Ingredients

Drugs in Other Trials (1)

niuchang (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1